Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2087-2094

  Ishizuka, Tamotsu ^a   Chayama, Kosuke ^a   Takeda, Katsuyuki ^a   Hamelmann, Eckard ^a   Terada, Naohiro ^a   Keller, Gordon M ^a   Johnson, Gary L ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIGEN; CALCINEURIN; CYCLOSPORIN A; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; SEROTONIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC TRANSCRIPTION; MAST CELL; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANDROSTADIENES; ANIMALS; BONE MARROW CELLS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCINEURIN; CYCLOSPORINE; ENZYME ACTIVATION; FEMALE; FLAVONOIDS; INTERLEUKIN-4; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAST CELLS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR AGGREGATION; RECEPTORS, IGE; SEROTONIN; SEROTONIN ANTAGONISTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033558357     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Eiseman, E., and J. B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinase. Nature 355:78.
2. Hutchcroft, J. E., R. L. Geahlen, G. G. Deanin, and J. M. Oliver. 1992. FcεRI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. Proc. Natl. Acad. Sci. USA 89:9107.
3. syk with the γ and β subunits of the high-affinity receptor for immunoglobulin E, FcεRI. Mol. Cell. Biol. 15:272.
4. Kawakami, Y., L. Yao, T. Miura, S. Tsukada, O. N. Witte, and T. Kawakami. 1994. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking. Mol. Cell. Biol. 14:5108.
5. Kawakami, Y., L. Yao, M. Tashiro, S. Gibson, G. M. Mills, and T. Kawakami. 1997. Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase. Itk/Tsk/Emt, on FcεRI cross-linking on mast cells. J. Immunol. 155:3556.
6. 2+ and purified isozynies in washed permeabilized cells. J. Biol. Chem. 268:1749.
7. Kawakami, T., N. Inagaki, M. Takei, H. Fukamachi, K. M. Coggeshall, K. Ishizaka, and T. Ishizaka. 1992. Tyrosine phosphorylation is required for mast cell activation by FcεRI cross-linking. J. Immunol. 148:3513.
8. Oliver, J. M., D. L. Burg, B. S. Wilson, J. L. McLaughlin, and R. L. Geablen. 1994. Inhibition of mast cell FcεRI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 269:29697.
9. Ishizuka, T., A. Oshiba, N. Sakata, N. Terada, G. L. Johnson, and E. W. Gelfand. 1996. Aggregation of the FcεRI on mast cells stimulates c-Jun amino-terminal kinase activity: a response inhibited by wortmannin. J. Biol. Chem. 271:12762.
10. Ishizuka, T., N. Terada, P. Gerwins, E. Hamelmann, A. Oshiba, G. R. Fanger, G. L. Johnson, and E. W. Gelfand. 1997. Mast cell tumor necrosis factor α production is regulated by MEK kinases. Proc. Natl. Acad. Sci. USA 94:6358.
11. Tsai, M., T. Takeishi, H. Thompson, K. E. Langley, K. M. Zsebo, D. D. Metcalfe, E. N. Geissler, and S. J. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88:6382.
12. Tsai, M., L.-S. Shih, G. F. J. Newlands, T. Takeishi, K. E. Langley, K. M. Zsebo, H. R. P. Miller, E. N. Geissler, and S. J. Galli. 1991. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo: analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174:125.
13. Zsebo, K. M., D. A. Williams, E. N. Geissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R.-Y. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock et al. 1990. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213.
14. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
15. Oshiba, A., E. Hamelmann, K. Takeda, K. L. Bradley, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Passive transfer of immediate bypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97-1398.
16. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719.
17. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069.
18. Cross, D. A. E., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785.
19. Bellacosa, A., J. R. Testa, S. P. Staal, and P. N. Tsichlis. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274
20. Franke, T. F., S.-I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727.
21. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665.
22. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3561.
23. Rottapel, R., M. Reedijk, D. E. Williams, S. D. Lyman, D. M. Anderson, T. Pawson, and A. Bernstein. 1991. The Steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor. Mol. Cell. Biol. 11:3043.
24. Trenn, G., R. Taffs, R. Hohman, R. Kincaid, E. M. Shevach, and M. Sitkovsky. 1989. Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions. J. Immunol. 142:3796.
25. 2+ fluxes. J. Immunol. 144:2659.
26. Cirillo, R., M. Triggiani, L. Siri, A. Ciccarelli, G. R. Pettit, M. Condorelli, and G. Marone. 1990. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J. Immunol. 144:3891.
27. Hatfield, S. M., and N. W. Roehm. 1991. Cyclosporin and FK506 inhibition of murine mast cell cytokine production. J. Pharmacol. Exp. Ther. 260:680.
28. Ryffel, B., G. Woerly, M. Murray, H.-P. Eugster, and B. Car. 1993. Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A. Biochem. Biophys. Res. Commun. 194:1074.
29. Handschumacher, R. E., M. W. Harding, J. Rice, and R. J. Drugge. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544.
30. LeGrue, S. J., R. Turner, N. Weisbrodt, and J. R. Dedman. 1986. Does the binding of cyclosporin to calmodulin result in immunosuppression? Science 234:68.
31. Gelfand, E. W., R. K. Cheung, and G. B. Mills. 1987. The cyclosporins inhibit lymphocyte activation at more than one site. J. Immunol. 138:1115.
32. Kaye, R. E., D. A. Fruman, B. E. Bierer, M. W. Albers, L. D. Zydowsky, S. I. Ho, Y.-J. Jin, M. C. Castells, S. L. Schreiber, C. T. Walsh, et al. 1992. Effects of cyclosporin A and FK506 on Fcε receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. USA 89:8542.
33. Liu, J., J. D. Farmer Jr., W. S. Lane, J. Friedman, I. Weissmann, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807.
34. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
35. Marquardt, D. L., J. L. Alongi, and L. L. Walker. 1996. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J. Immunol. 156:1942.
36. Kincaid, R. L. 1995. The role of calcineurin in immune system responses. J. Allergy Clin. Immunol. 96:1170
37. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 46:27489.
38. Pang, L., T. Sawada, S. J. Decker, and A. R. Saltiel. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem 270:13581.
39. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257.
40. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274.
41. Rao, A. 1995. NF-ATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J. Leukocyte Biol. 57:536.
42. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171:35.
43. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147:1694.
44. Economou, J. S., K. Rhoades, R. Essner, W. H. McBride, J. C. Gasson, and D. L. Morton. 1989. Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170:321.
45. Newell, C. L., A. B. Deisseroth, and G. Lopez-Berestein. 1994. Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-α gene. J. Leukocyte Biol. 56:27.
46. Krämer, B., K. Wiegmann, and M. Kronke. 1995. Regulation of the human TNF promoter by the transcription factor Ets. J. Biol. Chem. 270:6577.
47. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
48. Wenner, C. A., S. J. Szabo, and K. M. Murphy. 1997. Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J. Immunol. 158:765.
49. Aune, T. M., and R. A. Flavell. 1997. Differential expression of transcription directed by a discrete NF-AT binding element from IL-4 promoter in naive and effector CD4 T cells. J. Immunol. 159:36.
50. Kimura, K., S. Hattori, Y. Kabuyama, Y. Shizawa, J. Takayanagi, S. Nakamura, S. Toki, Y. Matsuda, K. Onodera, and Y. Fukui. 1994. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:18961.
51. Kotani, K., K. Yonezawa, K. Hara, H. Ueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, F. Grigorescu, M. Nishiyama, M. D. Waterfield, and M. Kasuga. 1994. Involvement of phosphoinositide 3-kinase in insulin-or IGF-1-induced membrane ruffling. EMBO J. 13:2313.
52. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:3568.
53. Arcaro, A., and M. P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297.
54. Ninomiya, N., K. Hazeki, Y. Fukui, T. Seya, T. Okada, O. Hazeki, and M. Ui. 1994. Involvement of phosphatidylinositol 3-kinase in Fcγ receptor signaling. J. Biol. Chem. 269:22732.
55. Ishizuka, T., H. Kawasome, N. Terada, K. Takeda, P. Gerwins, G. M. Keller, G. L. Johnson, and E. W. Gelfand. 1998. Stem cell factor augments Fc ε RI-mediated TNF-α production and stimulates MAP kinases via a different pathway in MC/9 mast cells. J. Immunol. 161:3642.
56. Flanagan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803.